Sec Form 13D Filing - Pangaea Ventures L.P. filing for RAYONIER ADVANCED MATLS INC CO (RYAM) - 2020-04-15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 2)*

Rayonier Advanced Materials Inc.

(Name of Issuer)

Common Stock, par value $0.01
(Title of Class of Securities)

75508B104
(CUSIP Number)

Ortelius Capital Partners, LLC

Ortelius Advisors, L.P.

c/o Peter DeSorcy

450 Park Avenue, Suite 2700
New York, NY 10022
(917) 595-5010
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

April 14, 2020

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

·       The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 75508B104

* Includes 1,450 shares of Common Stock beneficially owned by Mr. DeSorcy’s minor child.

This Amendment No. 2 to Schedule 13D (this “Amendment No. 2”) relates to the common stock, par value $0.01 per share (the “Common Stock”), of Rayonier Advanced Materials Inc., a Delaware corporation (the “Issuer”), and amends the Schedule 13D filed on March 6, 2020, as amended by Amendment No. 1 filed on April 1, 2020 (the “Original Schedule 13D”, and, together with this Amendment No. 2, the “Schedule 13D”) by the Reporting Persons (as defined below).  Any capitalized terms used and not defined in this Amendment No. 2 have the meanings set forth in the Original Schedule 13D.

This Amendment No. 2 is being filed on behalf of: (i) Pangaea Ventures, L.P., a Delaware limited partnership (“Pangaea”); (ii) Hudson Investors, Ltd., incorporated under the laws of the British Virgin Islands (“Hudson”); (iii) Ortelius Advisors, L.P., a Delaware limited partnership (“OA”); (iv) Ortelius Capital Partners, LLC, a Delaware limited liability company (“OC”); and (v) Peter DeSorcy (“Mr. DeSorcy”, and, together with Pangaea, Hudson, OA, OC, and Mr. DeSorcy, the “Reporting Persons”).

From April 1, 2020 through April 14, 2020, Pangaea sold a portion of the Common Stock owned by Pangaea in open market transactions, as described in further detail in Item 5 below.  This Amendment No. 2 is being filed to amend Item 5 of the Original Schedule 13D to reflect those sales.

Item 5. Interest in Securities of the Issuer

Item 5 of the Original Schedule 13D is hereby amended and restated as follows:

(a)  (b) As of the date of this Amendment No. 2, the Reporting Persons, in total, beneficially own 3,264,071 shares of Common Stock (the “Shares”). The Shares represent approximately 5.2% of the Issuer’s outstanding Common Stock. Percentages of the Common Stock outstanding reported in this Amendment No. 2 are calculated based upon the 63,171,700 shares of Common Stock outstanding as of February 25, 2020, as reported in the Issuer’s Annual Report on Form 10-K for the year ended December 31, 2019, filed by the Issuer with the Securities and Exchange Commission on March 2, 2020.    OA has voting and dispositive power over the shares of Common Stock held by Pangaea, and through ownership and control, Mr. DeSorcy has voting and dispositive power over portfolios managed by OA.  OC has voting and dispositive power over the shares of Common Stock held by Hudson, and, in turn, as the control person of OC, Mr. DeSorcy has voting and dispositive power over the shares of Common Stock held by Hudson.   In addition, Mr. DeSorcy has voting and dispositive power over the 1,450 shares of Common Stock beneficially owned by his minor child.

The Shares beneficially owned by the Reporting Persons identified in this Amendment No. 2 include a total of 1,486,715 shares of Common Stock sold by Pangaea in open market transactions  effected from March 23, 2020 through April 14, 2020, and as a result Pangaea no longer has an economic interest in those Shares that it sold.   However, notwithstanding such sales, Pangaea owned those Shares as of March 20, 2020, the record date (the “Record Date”) for the Issuer’s annual meeting of stockholders to be held on May 18, 2020 (the “Annual Meeting”), and thus remains entitled to direct the vote of such Shares for purposes of the Annual Meeting.

(c) Set forth on Schedule A hereto are all transactions of Common Stock during the past sixty days effected by any Reporting Person.

(d) Other than Pangaea and Hudson that beneficially hold shares of Common Stock of the Issuer as identified in this Schedule 13D, and except as set forth in this Item 5, no other person is known to have the right to receive, or the power to direct the receipt of, dividends from or proceeds from the sale, of the shares of Common Stock beneficially owned by Pangaea or Hudson.  No person other than Mr. DeSorcy is known to have the right to receive, or the power to direct the receipt of, dividends from or proceeds from the sale of, the shares of Common Stock beneficially owned by his minor child.

(e)   Pangaea sold a total of 736,870 of the Shares in transactions effected on March 23, 2020 through March 27, 2020, and then sold a total of an additional 749,845 Shares in transactions effected on April 1, 2020 through April 14, 2020, and as a result Pangaea no longer has an economic interest in those Shares that it sold.   However, because the Reporting Persons owned such Shares on the Record Date, the Reporting Persons retained voting power over such Shares for purposes of the Annual Meeting.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

SCHEDULE A

This Schedule A sets forth information with respect to each purchase and sale of Shares which was effectuated by Pangaea during the past sixty days. All transactions were effectuated in the open market through a broker.

INDEX TO EXHIBITS

*Previously filed.